Home Topics OMICs RNAi Technology RNAi Technology March 22, 2007 – GEN’s Editor-in-Chief John Sterling interviews Richard Jorgensen, Ph.D., from the University of Arizona /wp-content/uploads/2018/09/gc87_3_22_2007.mp3 PodcastsResourcesCellular, Molecular and Developmental BiologyMolecular biologyNucleic acidsRNARNA biologyRNA interference Also of Interest Universal Vaccine Strategy Boosts Body's RNAi Response to Viruses SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR New Insights Could Boost Immunotherapy for Rare Eye Cancer Long-Lived RNA in Nerve Cells Can Last a Lifetime Novel RNA Therapeutic Modalities Simplifying Scale-up Manufacturing of RNA-LNPs for Vaccine and Cell Therapy Applications Related Media Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix The Sun Sets on AGBT: A Report from the Last Day Spatial, Sequencing, and Sun: A Report from Day 2 of AGBT Sand, Sea, and Sequencing: Julianna LeMieux Surfs up AGBT's Hot News Decoding Genomic Diversity with deCODE Genetics CEO Kári Stefánsson on "Close to the Edge" Related Content Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR New Insights Could Boost Immunotherapy for Rare Eye Cancer Long-Lived RNA in Nerve Cells Can Last a Lifetime